A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion

Haitham Hamoda, Premila Wencesiaus Ashok, Alexander Allan Templeton, G. M. Flett

    Research output: Contribution to journalArticle

    35 Citations (Scopus)

    Abstract

    Objective: The purpose of this study was to compare the effectiveness of the sublingual and vaginal administration of misoprostol for cervical priming before surgical termination of pregnancy.
    Study design: In a randomized controlled trial, 74 primigravid women who were undergoing surgical abortion were assigned randomly to receive misoprostol (400 mug) sublingually or vaginally.
    Results: There was no statistically significant difference in the cumulative force that was required to dilate the cervix to 9 mm, for baseline cervical dilatation, for priming to abortion interval, for operating time, or for intraoperative blood loss between the two groups. Women in the sublingual group had more nausea (P=.008), vomiting (P=.01), diarrhea (P=.01), and unpleasant mouth taste (P=.0001) compared with the women in the vaginal group. In the sublingual group, 65% of women were satisfied with the route of misoprostol administration compared with 78% in the vaginal group (P=.11). Most of the staff members (84%) said that they would recommend the sublingual administration of misoprostol (P=.0001).
    Conclusion: The sublingual administration of misoprostol is an effective alternative to vaginal administration for cervical priming before surgical abortion; despite a higher incidence of side effects, there was high patient and staff acceptability. (C) 2004 Elsevier Inc. All rights reserved.

    Original languageEnglish
    Pages (from-to)55-59
    Number of pages4
    JournalAmerican Journal of Obstetrics and Gynecology
    Volume190
    Issue number1
    DOIs
    Publication statusPublished - Jan 2004

    Keywords

    • surgical abortion
    • cervical priming
    • misoprostol
    • sublingual administration
    • vaginal administration
    • vacuum aspiration
    • medical abortion
    • oral Misoprostol
    • pregnancy termination
    • curettage abortion
    • weeks gestation
    • Mifepristone
    • dilatation
    • Gemeprost
    • trial

    Cite this

    A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion. / Hamoda, Haitham; Ashok, Premila Wencesiaus; Templeton, Alexander Allan; Flett, G. M.

    In: American Journal of Obstetrics and Gynecology, Vol. 190, No. 1, 01.2004, p. 55-59.

    Research output: Contribution to journalArticle

    @article{0ac70b8dce544301b4e2fb718aeb796d,
    title = "A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion",
    abstract = "Objective: The purpose of this study was to compare the effectiveness of the sublingual and vaginal administration of misoprostol for cervical priming before surgical termination of pregnancy. Study design: In a randomized controlled trial, 74 primigravid women who were undergoing surgical abortion were assigned randomly to receive misoprostol (400 mug) sublingually or vaginally. Results: There was no statistically significant difference in the cumulative force that was required to dilate the cervix to 9 mm, for baseline cervical dilatation, for priming to abortion interval, for operating time, or for intraoperative blood loss between the two groups. Women in the sublingual group had more nausea (P=.008), vomiting (P=.01), diarrhea (P=.01), and unpleasant mouth taste (P=.0001) compared with the women in the vaginal group. In the sublingual group, 65{\%} of women were satisfied with the route of misoprostol administration compared with 78{\%} in the vaginal group (P=.11). Most of the staff members (84{\%}) said that they would recommend the sublingual administration of misoprostol (P=.0001). Conclusion: The sublingual administration of misoprostol is an effective alternative to vaginal administration for cervical priming before surgical abortion; despite a higher incidence of side effects, there was high patient and staff acceptability. (C) 2004 Elsevier Inc. All rights reserved.",
    keywords = "surgical abortion, cervical priming, misoprostol, sublingual administration, vaginal administration, vacuum aspiration, medical abortion, oral Misoprostol, pregnancy termination, curettage abortion, weeks gestation, Mifepristone, dilatation, Gemeprost, trial",
    author = "Haitham Hamoda and Ashok, {Premila Wencesiaus} and Templeton, {Alexander Allan} and Flett, {G. M.}",
    year = "2004",
    month = "1",
    doi = "10.1016/j.ajog.2003.08.025",
    language = "English",
    volume = "190",
    pages = "55--59",
    journal = "American Journal of Obstetrics and Gynecology",
    issn = "0002-9378",
    publisher = "Mosby/Elsevier,",
    number = "1",

    }

    TY - JOUR

    T1 - A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion

    AU - Hamoda, Haitham

    AU - Ashok, Premila Wencesiaus

    AU - Templeton, Alexander Allan

    AU - Flett, G. M.

    PY - 2004/1

    Y1 - 2004/1

    N2 - Objective: The purpose of this study was to compare the effectiveness of the sublingual and vaginal administration of misoprostol for cervical priming before surgical termination of pregnancy. Study design: In a randomized controlled trial, 74 primigravid women who were undergoing surgical abortion were assigned randomly to receive misoprostol (400 mug) sublingually or vaginally. Results: There was no statistically significant difference in the cumulative force that was required to dilate the cervix to 9 mm, for baseline cervical dilatation, for priming to abortion interval, for operating time, or for intraoperative blood loss between the two groups. Women in the sublingual group had more nausea (P=.008), vomiting (P=.01), diarrhea (P=.01), and unpleasant mouth taste (P=.0001) compared with the women in the vaginal group. In the sublingual group, 65% of women were satisfied with the route of misoprostol administration compared with 78% in the vaginal group (P=.11). Most of the staff members (84%) said that they would recommend the sublingual administration of misoprostol (P=.0001). Conclusion: The sublingual administration of misoprostol is an effective alternative to vaginal administration for cervical priming before surgical abortion; despite a higher incidence of side effects, there was high patient and staff acceptability. (C) 2004 Elsevier Inc. All rights reserved.

    AB - Objective: The purpose of this study was to compare the effectiveness of the sublingual and vaginal administration of misoprostol for cervical priming before surgical termination of pregnancy. Study design: In a randomized controlled trial, 74 primigravid women who were undergoing surgical abortion were assigned randomly to receive misoprostol (400 mug) sublingually or vaginally. Results: There was no statistically significant difference in the cumulative force that was required to dilate the cervix to 9 mm, for baseline cervical dilatation, for priming to abortion interval, for operating time, or for intraoperative blood loss between the two groups. Women in the sublingual group had more nausea (P=.008), vomiting (P=.01), diarrhea (P=.01), and unpleasant mouth taste (P=.0001) compared with the women in the vaginal group. In the sublingual group, 65% of women were satisfied with the route of misoprostol administration compared with 78% in the vaginal group (P=.11). Most of the staff members (84%) said that they would recommend the sublingual administration of misoprostol (P=.0001). Conclusion: The sublingual administration of misoprostol is an effective alternative to vaginal administration for cervical priming before surgical abortion; despite a higher incidence of side effects, there was high patient and staff acceptability. (C) 2004 Elsevier Inc. All rights reserved.

    KW - surgical abortion

    KW - cervical priming

    KW - misoprostol

    KW - sublingual administration

    KW - vaginal administration

    KW - vacuum aspiration

    KW - medical abortion

    KW - oral Misoprostol

    KW - pregnancy termination

    KW - curettage abortion

    KW - weeks gestation

    KW - Mifepristone

    KW - dilatation

    KW - Gemeprost

    KW - trial

    U2 - 10.1016/j.ajog.2003.08.025

    DO - 10.1016/j.ajog.2003.08.025

    M3 - Article

    VL - 190

    SP - 55

    EP - 59

    JO - American Journal of Obstetrics and Gynecology

    JF - American Journal of Obstetrics and Gynecology

    SN - 0002-9378

    IS - 1

    ER -